fluconazole and t-2307

fluconazole has been researched along with t-2307 in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Fukuda, Y; Imamura, Y; Izumikawa, K; Kakeya, H; Kohno, S; Mitsuyama, J; Miyazaki, T; Mukae, H; Nakamura, S; Nishikawa, H; Saijo, T; Takazono, T; Tanaka, A; Tashiro, M; Yamamoto, K; Yamamoto, Y; Yanagihara, K	1

Other Studies

1 other study(ies) available for fluconazole and t-2307

Article	Year
In vitro and in vivo antifungal activities of T-2307, a novel arylamidine, against Cryptococcus gattii: an emerging fungal pathogen. The Journal of antimicrobial chemotherapy, 2017, 06-01, Volume: 72, Issue:6 Topics: Amidines; Amphotericin B; Animals; Antifungal Agents; Brain; Cryptococcosis; Cryptococcus gattii; Cryptococcus neoformans; Disease Models, Animal; Drug Discovery; Drug Resistance, Fungal; Fluconazole; Humans; Lung; Lung Diseases, Fungal; Mice; Microbial Sensitivity Tests; Voriconazole	2017

Article

Year

In vitro and in vivo antifungal activities of T-2307, a novel arylamidine, against Cryptococcus gattii: an emerging fungal pathogen.

The Journal of antimicrobial chemotherapy, 2017, 06-01, Volume: 72, Issue:6

Topics: Amidines; Amphotericin B; Animals; Antifungal Agents; Brain; Cryptococcosis; Cryptococcus gattii; Cryptococcus neoformans; Disease Models, Animal; Drug Discovery; Drug Resistance, Fungal; Fluconazole; Humans; Lung; Lung Diseases, Fungal; Mice; Microbial Sensitivity Tests; Voriconazole

2017